FROM A-LEVELS OR AN OVERSEAS DEGREE TO PRACTISING IN THE UKSearch the guide
← All news
NEW MEDICINES AND DRUG DISCOVERY · FDA: PRESS ANNOUNCEMENTS · 14 October 2026

FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer

Synopsis

NMIBC is bladder cancer that has not grown into the bladder’s muscle layer and can include CIS and papillary tumors. CIS is always high-grade, while papillary tumors can be low-grade or high-grade.

Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.

Read the full story at FDA: press announcements ↗

More in New medicines and drug discovery